Login / Signup

Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs).

Marcin OrzechowskiMaximilian SchochowMichael KühlFlorian Steger
Published in: Stem cell research & therapy (2020)
Given the unique character of iPSCs and the possibility of their various uses in the future, the content of donor information should contain specific information central to iPSC research. Effective methods of communicating information to donors should combine written and oral information with the possible use of multimedia.
Keyphrases
  • induced pluripotent stem cells
  • health information
  • healthcare
  • adverse drug